Published online June 2, 2008
PEDIATRICS Vol. 121 No. 6 June 2008, pp. e1585-e1590 (doi:10.1542/peds.2007-2111)

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bowden, S. A. Articles by Mahan, J. D. Search for Related Content PubMed PubMed Citation Articles by Bowden, S. A. Articles by Mahan, J. D. Related Collections Nutrition & Metabolism Social Bookmarking                         What's this?

ARTICLE

Prevalence of Vitamin D Deficiency and Insufficiency in Children With Osteopenia or Osteoporosis Referred to a Pediatric Metabolic Bone Clinic

Sasigarn A. Bowden, MD^a, Renee F. Robinson, PharmD, MPH^b, Roxane Carr, PharmD^b and John D. Mahan, MD^b

^a Divisions of Endocrinology
^b Nephrology, Department of Pediatrics, Columbus Children's Hospital/Ohio State University College of Medicine, Columbus, Ohio

OBJECTIVES. The purpose of this work was to determine the prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis and to evaluate the relationship between serum 25-hydroxyvitamin D levels and bone parameters, including bone mineral density.

MATERIALS AND METHODS. Serum 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, parathyroid hormone, and other bone markers, as well as bone mineral density, were obtained for 85 pediatric patients with primary osteoporosis (caused by osteogenesis imperfecta or juvenile idiopathic osteoporosis) and secondary osteopenia or osteoporosis caused by various underlying chronic illnesses. Pearson's correlation was used to assess the relationship between vitamin D levels and different bone parameters.

RESULTS. Vitamin D insufficiency (defined as serum 25-hydroxyvitamin D <30 ng/mL) was observed in 80.0% of patients. Overt vitamin D deficiency (defined as serum 25-hydroxyvitamin D <10 ng/mL) was present in 3.5% of patients. Using a more recent definition for vitamin D deficiency in adults (defined as serum 25-hydroxyvitamin D <20 ng/mL), 21.1% of the patients had vitamin D deficiency. There was a significant inverse correlation between 25-hydroxyvitamin D and parathyroid hormone levels. There was a positive correlation between 1,25 dihydroxyvitamin D and parathyroid hormone, alkaline phosphatase, and urine markers for bone turnover.

CONCLUSIONS. Vitamin D insufficiency was remarkably common in pediatric patients with primary and secondary osteopenia or osteoporosis. The inverse relationship between 25-hydroxyvitamin D and parathyroid hormone levels suggests a physiologic impact of insufficient vitamin D levels that may contribute to low bone mass or worsen the primary bone disease. We suggest that monitoring and supplementation of vitamin D should be a priority in the management of pediatric patients with osteopenia or osteoporosis.

---

Key Words: vitamin D deficiency • vitamin D insufficiency • pediatric osteopenia • pediatric osteoporosis • low bone density in children

Abbreviations: 25-OHD—25-hydroxyvitamin D • PTH—parathyroid hormone • BMD—bone mineral density • 1,25-OHD—1,25-dihydroxyvitamin D • CV—coefficient of variation

---

Accepted Nov 26, 2007.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. L. Bianchi Diagnosis and Treatment of Bone Fragility in Childhood IBMS BoneKEy, September 1, 2008; 5(9): 323 - 335. [Abstract] [Full Text] [PDF]